DAE HWA Pharmaceutical Co., Ltd.
Research DAE HWA Pharmaceutical Co., Ltd. (067080.KQ) on Bullrun: market cap KRW 197.30B, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker067080.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 197.30B
- Dividend yield1.4%
- Financial periodQ2 2026
- RevenueKRW 41.29B
- Net incomeKRW 1.93B
- Free cash flow-KRW 2.37B
- Gross margin38.0%
Valuation Snapshot
latest market cap is KRW 197.30B; dividend yield is 1.4%.
Peer valuation comparison
Latest dividend yield is 1.4% versus a Healthcare sector median of 2.4% (41.7% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 197.30B | n/a | 1.4% | 150 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 150 KRW, yield 1.4%.
About DAE HWA Pharmaceutical Co., Ltd.
DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is DAE HWA Pharmaceutical Co., Ltd.'s market cap?
DAE HWA Pharmaceutical Co., Ltd.'s market capitalization is KRW 197.30B.
Does DAE HWA Pharmaceutical Co., Ltd. pay a dividend?
DAE HWA Pharmaceutical Co., Ltd. has a dividend yield of 1.4%.
What does DAE HWA Pharmaceutical Co., Ltd. do?
DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea.